SCHEMBL13429005

SCHEMBL13429005

[C-]#[N+]c1c(N)nc(SCc2ccc(C(F)(F)F)nc2)c(C#N)c1SC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 5/20 0.38
ADORA1 P30542 8/20 0.38
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
DAO P14920 2/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
ADORA2A P29274 2/20 0.35
HTT P42858 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ADORA3 P0DMS8 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 2/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15685569 0.88 RET (0.41) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13429007 0.86 RET (0.42) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13429003 0.84 RET (0.43) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13429071 0.82 ALDH1A1 (0.35) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13456494 0.73 RET (0.47) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13456498 0.73 ALDH1A1 (0.38) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13428998 0.73 ADORA1 (0.47) ADORA1ALDH1A1KMT2AHTTSMN1; SMN2
SCHEMBL13456539 0.73 RET (0.42) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13456493 0.72 RET (0.43) RETADORA1KDM4EALDH1A1HPGD
SCHEMBL13472211 0.71 RET (0.47) RETADORA1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8703934-B2 Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-04-22 US disclosed
US-20100069363-A1 SUBSTITUTED 4-AMINO-3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069363-A1 SUBSTITUTED 4-AMINO-3,5-DICYANO-2-THIOPYRIDINES AND USE THEREOF QDPR, DDC, TPMT RET 1200/4885ADORA1 1199/4885KDM4E 489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.